Institutional Ownership Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH). We have compiled data on the 23 institutions that hold shares in the stock, with a total of 2.24 Million shares, which have been reported (via 13F filing form) to have a value of $1.68 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Epiq Capital Group, LLC
San Francisco, CA |
Aug 09, 2024 Q2 2024 |
817,270
shares
|
$612,952
0.39% of portfolio
|
Q2 2024
Reduced 4.28%
|
|
Founders Fund V Management, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
480,708
shares
|
$360,531
72.16% of portfolio
|
Q4 2023
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
446,573
shares
|
$334,929
0.0% of portfolio
|
Q2 2024
Added 12.58%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
175,418
shares
|
$131,563
0.0% of portfolio
|
Q2 2024
Added 9.81%
|
|
Founders Fund Vi Management, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
110,023
shares
|
$82,517
100.0% of portfolio
|
Q4 2023
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
59,510
shares
|
$44,632
0.0% of portfolio
|
Q2 2024
Added 60.29%
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
39,530
shares
|
$29,647
0.0% of portfolio
|
Q1 2024
Added 0.01%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
24,670
shares
|
$18,502
0.0% of portfolio
|
Q2 2024
New holding
|
|
Wealth Enhancement Advisory Services, LLC
|
Oct 23, 2024 Q3 2024 |
23,400
shares
|
$17,550
0.0% of portfolio
|
Q3 2024
Added 14.71%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
21,722
shares
|
$16,291
0.0% of portfolio
|
Q2 2024
Reduced 0.09%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
13,356
shares
|
$10,017
0.0% of portfolio
|
Q2 2024
Reduced 38.61%
|
|
Ubs Group Ag
|
Aug 13, 2024 Q2 2024 |
12,053
shares
|
$9,039
0.0% of portfolio
|
Q2 2024
Added 149.65%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Aug 13, 2024 Q2 2024 |
4,999
shares
|
$3,749
0.0% of portfolio
|
Q2 2024
Reduced 24.05%
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 13, 2024 Q2 2024 |
4,391
shares
|
$3,293
0.0% of portfolio
|
Q2 2024
Reduced 3.81%
|
|
Princeton Global Asset Management LLC
|
Oct 29, 2024 Q3 2024 |
3,466
shares
|
$2,599
0.0% of portfolio
|
Q3 2024
Reduced 7.97%
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
1,031
shares
|
$773
0.0% of portfolio
|
Q2 2024
Reduced 0.58%
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2024 Q2 2024 |
746
shares
|
$559
0.0% of portfolio
|
Q2 2021
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
210
shares
|
$157
0.0% of portfolio
|
Q2 2024
Added 677.78%
|
|
Jpmorgan Chase & CO
New York, NY |
Aug 12, 2024 Q2 2024 |
153
shares
|
$114
0.0% of portfolio
|
Q1 2024
Added 750.0%
|
|
Steward Partners Investment Advisory, LLC
|
Aug 08, 2024 Q2 2024 |
90
shares
|
$67
0.0% of portfolio
|
Q4 2023
New holding
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Aug 13, 2024 Q2 2024 |
67
shares
|
$50
0.0% of portfolio
|
Q1 2024
Reduced 88.83%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2024 Q2 2024 |
21
shares
|
$15
0.0% of portfolio
|
Q1 2024
Reduced 82.64%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|